A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Up to 50% of patients diagnosed with advanced melanoma develop brain metastases during the course of their disease. The prognosis of melanoma patients is heavily affected by the presence of brain metastases. Unfortunately, there is a lack of data on prognostic factors for these patie...

Descripción completa

Detalles Bibliográficos
Autores principales: van Not, Olivier J., Wind, Thijs T., Ismail, Rawa K., Bhattacharya, Arkajyoti, Jalving, Mathilde, Blank, Christian U., Aarts, Maureen J. B., van den Berkmortel, Franchette W. P. J., Boers-Sonderen, Marye J., van den Eertwegh, Alfonsus J. M., de Groot, Jan Willem B., Haanen, John B., Kapiteijn, Ellen, Bloem, Manja, Piersma, Djura, van Rijn, Rozemarijn S., Stevense-den Boer, Marion, van der Veldt, Astrid A. M., Vreugdenhil, Gerard, Wouters, Michel W. J. M., Blokx, Willeke A. M., Suijkerbuijk, Karijn P. M., Fehrmann, Rudolf S. N., Hospers, Geke A. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252066/
https://www.ncbi.nlm.nih.gov/pubmed/37296885
http://dx.doi.org/10.3390/cancers15112922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252066/
https://www.ncbi.nlm.nih.gov/pubmed/37296885
http://dx.doi.org/10.3390/cancers15112922

Ejemplares similares